SCHEMBL2641937

SCHEMBL2641937

c1ccc(-c2cccc(-n3cnc4cccnc43)c2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.46
GABRD O14764 2/20 0.46
GABRA1 P14867 2/20 0.46
GABRB1 P18505 2/20 0.46
GABRG2 P18507 2/20 0.46
GABRB3 P28472 2/20 0.46
GABRA5 P31644 2/20 0.46
GABRA3 P34903 2/20 0.46
GABRA2 P47869 2/20 0.46
GABRB2 P47870 2/20 0.46
GABRA4 P48169 2/20 0.46
GABRE P78334 2/20 0.46
GABRA6 Q16445 2/20 0.46
GABRG1 Q8N1C3 2/20 0.46
GABRG3 Q99928 2/20 0.46
GABRQ Q9UN88 2/20 0.46
KMT2A Q03164 1/20 0.45
PDE10A Q9Y233 1/20 0.44
HTT P42858 1/20 0.44
FGFR1 P11362 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11973865 0.87 GABRP (0.52) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL2641984 0.86 MAPT (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1858815 0.85 HTT (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL27092725 0.84 GABRA1 (0.41) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL30269609 0.80 HPGD (0.48) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL6800940 0.80 GAK (0.54) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL26709174 0.80 FGFR1 (0.41) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL4015486 0.80 HTT (0.71) KMT2AHTTFGFR1
SCHEMBL27728438 0.77 FGFR1 (0.48) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL2642010 0.76 HTT (0.44) KMT2AHTTFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11600791-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-03-07 US disclosed
EP-0563001-B1 Imidazole compounds, their preparation and use NEUROSEARCH AS (DK) 1996-02-28 EP disclosed
US-5360809-A Imidazole compounds and their use as calcium channel blockers NEUROSEARCH A/S (DK) 1994-11-01 US disclosed
EP-0563001-A1 Imidazole compounds, their preparation and use NEUROSEARCH A/S (DK) 1993-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11600791-B2 Organic electroluminescent materials and devices NUDC, NCL, NDC1 GABRP 537/4885GABRD 3130/4885GABRA1 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.